Johnson & Johnson.

Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with its pharmacy benefit manager, CVS Caremark. The lawsuit, filed late last week in U.S. District Court for the Southern District of New York, seeks to recover any overpaid costs and ensure that the plan complies with ERISA in the future.

Plaintiffs claim that the bank’s failure to properly oversee its PBM contract resulted in unnecessarily high prescription drug costs, thereby violating the best interests of employees under ERISA. As an example, lawsuit cites the plan’s purchase of the multiple sclerosis drug teriflunomide, which allegedly was purchased for $6,229, compared to about $30 at retail pharmacies.


NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2025 ALM Global, LLC. All Rights Reserved.